Roadshow: Health Technologies
The roadshow also offered Ambassador Cujba and the BAI team a unique opportunity to explore the symbiosis between cutting-edge medical technologies and time-honored traditional medical practices. In an era where AI, robotics, and advanced imaging redefine healthcare delivery, innovation increasingly combines precision technology with holistic health philosophies.
Portable Diagnostics for Emergency and Remote Care
The delegation visited Guoke Xiguang (Suzhou) Technology Co., Ltd., a high-tech enterprise specializing in lightweight, low-radiation portable X-ray imaging systems. The company focuses on high-end medical imaging localization and innovation, drawing on expertise in ultra-fast and ultra-weak signal detection technologies developed in cooperation with research institutions, including laboratories affiliated with the Chinese Academy of Sciences.
Guoke Xiguang’s portable X-ray devices are designed to provide rapid diagnostic capabilities in urgent situations. Their lightweight construction and reduced radiation exposure enable deployment in emergency response scenarios, ambulance services, ICUs, disaster zones, peacekeeping missions, sports events, and remote or underserved regions where access to full-scale radiology equipment is limited.
The company’s multidisciplinary team – including specialists in engineering, physics, optics, imaging science, clinical medicine, algorithms, and software-hardware integration – reflects a strong foundation in research and technological innovation. By prioritizing mobility, safety, and precision, Guoke Xiguang contributes directly to SDG 3 (Good Health and Well-Being), especially in strengthening healthcare systems in fragile or geographically isolated contexts.
Rehabilitation Robotics: Restoring Mobility and Dignity
BAI also visited Beijing Daai Robot Technology Co., Ltd., a pioneer and leading provider of exoskeleton-based rehabilitation robotics in China. The company is recognized for its original R&D in robotic-assisted rehabilitation and has played a foundational role in establishing the domestic exoskeleton rehabilitation industry.
Daai’s exoskeleton robots are designed to support patients recovering from stroke, spinal cord injuries, paraplegia, and other severe neurological conditions. The systems integrate bionic walking design, intelligent control platforms, and AI-supported rehabilitation assessment tools. The company has developed a comprehensive clinical ecosystem – including hospital-based rehabilitation solutions, cloud assessment platforms, intelligent rehabilitation engineering systems, and home-based rehabilitation technologies.
With years of treatment application and extensive clinical verification, Daai’s product portfolio now spans multiple series covering different age groups, disease conditions, and rehabilitation stages – from early passive training to active rehabilitation and home mobility support. Its technology reduces long-term disability burdens, supports patient reintegration into society, and enhances quality of life for individuals and families.
The visit demonstrated how robotics, AI, and biomedical engineering can be directed toward inclusive development, disability support, and social reintegration – contributing to SDGs 3 and 10 (Reduced Inequalities).
Traditional Medicine, Sustainable Agriculture and Cultural Revival
In contrast yet complementary to high-tech robotics and imaging systems, the delegation visited Wenshan Ama Health Technology Co., Ltd., a third-generation family enterprise based in Wenshan, Yunnan – known as the “City of Panax Notoginseng.”
The company has developed a dual-driven strategy integrating an agricultural industry chain and a health industry chain, forming a closed-loop ecosystem from cultivation and research to production and international sales. Leveraging Wenshan’s unique ecological conditions and centuries-old cultivation traditions, the company selects premium-grade Panax notoginseng – historically described by Ming Dynasty pharmacologist Li Shizhen as “more valuable than gold.”
By combining responsible agricultural practices, technological innovation, and standardized production processes, Wenshan Ama bridges traditional Chinese medicine with modern health product development. Its “raw materials + health supplements + health foods” model reflects growing global interest in preventive healthcare and natural wellness approaches.
This integration of cultural heritage, ecological agriculture, and scientific validation illustrates how traditional knowledge systems can coexist with advanced technologies – supporting SDGs 3, 8, 12 (Responsible Consumption and Production), and 15 (Life on Land).
A Converging Health Ecosystem
Together, the three companies represent complementary dimensions of modern healthcare innovation:
Rapid diagnostic technologies for emergency and underserved environments
Robotic rehabilitation systems restoring mobility and dignity
Sustainable, culturally rooted natural health solutions
All three rely on advanced research, engineering excellence, digital technologies, and responsible production systems. Their approaches demonstrate that 21st-century health development does not rely solely on digital breakthroughs or traditional wisdom alone – but increasingly on their convergence.
For BAI, these visits reinforced the understanding that technological innovation, when aligned with human well-being and cultural context, becomes a powerful instrument for inclusive and sustainable development.